{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T00:11:11Z","timestamp":1793319071442,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:00:00Z","timestamp":1603843200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["18\/TIDA\/6017"],"award-info":[{"award-number":["18\/TIDA\/6017"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ir J Med Sci"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s11845-020-02421-1","type":"journal-article","created":{"date-parts":[[2020,10,28]],"date-time":"2020-10-28T00:32:01Z","timestamp":1603845121000},"page":"971-979","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Recent trends in renal denervation devices for resistant hypertension treatment"],"prefix":"10.1007","volume":"190","author":[{"given":"Sumeeyae","family":"Haribabu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Sharif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0300-7446","authenticated-orcid":false,"given":"Haroon","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,28]]},"reference":[{"issue":"9455","key":"2421_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","volume":"365","author":"PM Kearney","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365(9455):217\u2013223","journal-title":"Lancet"},{"issue":"9349","key":"2421_CR2","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","volume":"360","author":"S Lewington","year":"2002","unstructured":"Lewington S, Clarke R, Qizilbash N et al (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360(9349):1903\u20131913","journal-title":"Lancet"},{"issue":"16","key":"2421_CR3","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1161\/CIRCULATIONAHA.113.005663","volume":"129","author":"P Alessandro","year":"2014","unstructured":"Alessandro P et al (2014) Predictors of long-term recurrent vascular events after ischemic stroke at young age. Circulation 129(16):1668\u20131676","journal-title":"Circulation"},{"issue":"1","key":"2421_CR4","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1161\/CIR.0b013e318245fac5","volume":"125","author":"VL Roger","year":"2012","unstructured":"Roger VL, Go AS, Lloyd-Jones DM et al (2012) Heart disease and stroke statistics-2012 update: a report from the American heart association. Circulation 125(1):e2\u2013e220","journal-title":"Circulation"},{"issue":"25","key":"2421_CR5","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1161\/CIRCULATIONAHA.108.189141","volume":"117","author":"DA Calhoun","year":"2008","unstructured":"Calhoun DA, Jones D, Textor S et al (2008) Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 117(25):e510\u2013e526","journal-title":"Circulation"},{"issue":"9671","key":"2421_CR6","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0140-6736(09)60566-3","volume":"373","author":"H Krum","year":"2009","unstructured":"Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275\u20131281","journal-title":"Lancet"},{"issue":"3","key":"2421_CR7","first-page":"58","volume":"289","author":"GF DiBona","year":"2005","unstructured":"DiBona GF (2005) Physiology in perspective: The Wisdom of the Body. Neural control of the kidney. Am J Phys Regul Integr Comp Phys 289(3):58\u201353 pp. R633\u2013R641","journal-title":"Am J Phys Regul Integr Comp Phys"},{"issue":"2","key":"2421_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/00041552-200203000-00011","volume":"11","author":"GF DiBona","year":"2002","unstructured":"DiBona GF (2002) Sympathetic nervous system and the kidney in hypertension. Curr Opin Nephrol Hypertens 11(2):197\u2013200","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"5","key":"2421_CR9","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/0272-6386(95)90456-5","volume":"26","author":"VM Campese","year":"1995","unstructured":"Campese VM, Kogosov E, Koss M (1995) Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat. Am J Kidney Dis 26(5):861\u2013865","journal-title":"Am J Kidney Dis"},{"key":"2421_CR10","doi-asserted-by":"crossref","unstructured":"Al Raisi SI, Pouliopoulos J, Swinnen J et al (2019) Renal artery denervation in resistant hypertension: the good, the bad and the future. Heart Lung Circ","DOI":"10.1016\/j.hlc.2019.06.723"},{"issue":"1","key":"2421_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1152\/physrev.1997.77.1.75","volume":"77","author":"GF DiBona","year":"1997","unstructured":"DiBona GF, Kopp UC (1997) Neural control of renal function. Physiol Rev 77(1):75\u2013197","journal-title":"Physiol Rev"},{"issue":"2","key":"2421_CR12","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1161\/CIRCULATIONAHA.110.971580","volume":"123","author":"H Krum","year":"2011","unstructured":"Krum H, Sobotka P, Mahfoud F et al (2011) Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 123(2):209\u2013215","journal-title":"Circulation"},{"key":"2421_CR13","doi-asserted-by":"crossref","unstructured":"Michael Froeschl et al (2013) Renal sympathetic denervation for resistant hypertension. Can. J. Cardiol. 29(5):636\u2013638","DOI":"10.1016\/j.cjca.2013.02.019"},{"issue":"1","key":"2421_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1161\/01.HYP.11.1.3","volume":"11","author":"M Esler","year":"1988","unstructured":"Esler M, Jennings G, Korner P et al (1988) Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertens (Dallas, Tex 1979) 11(1):3\u201320","journal-title":"Hypertens (Dallas, Tex 1979)"},{"issue":"6 Pt 2","key":"2421_CR15","doi-asserted-by":"publisher","first-page":"99S","DOI":"10.1016\/S0895-7061(00)00225-9","volume":"13","author":"M Esler","year":"2000","unstructured":"Esler M (2000) The sympathetic system and hypertension. Am J Hypertens 13(6 Pt 2):99S\u2013105S","journal-title":"Am J Hypertens"},{"key":"2421_CR16","doi-asserted-by":"crossref","unstructured":"Gulati V, White WB (2013) Novel approaches for the treatment of the patient with resistant hypertension: renal nerve ablation. Curr Cardiovasc Risk Rep 7(5)","DOI":"10.1007\/s12170-013-0334-9"},{"key":"2421_CR17","doi-asserted-by":"crossref","unstructured":"Goldsmith D, Covic A, and Spaak J (2015) Cardio-renal clinical challenges. Springer","DOI":"10.1007\/978-3-319-09162-4"},{"issue":"9917","key":"2421_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","volume":"383","author":"H Krum","year":"2014","unstructured":"Krum H, Schlaich MP, Sobotka PA et al (2014) Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 383(9917):622\u2013629","journal-title":"Lancet"},{"key":"2421_CR19","doi-asserted-by":"crossref","unstructured":"(2010) Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 376(9756):1903\u20131909","DOI":"10.1016\/S0140-6736(10)62039-9"},{"issue":"15","key":"2421_CR20","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","volume":"370","author":"DL Bhatt","year":"2014","unstructured":"Bhatt DL, Kandzari DE, O'Neill WW et al (Mar. 2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370(15):1393\u20131401","journal-title":"N Engl J Med"},{"issue":"2","key":"2421_CR21","first-page":"93","volume":"38","author":"F Mahfoud","year":"2016","unstructured":"Mahfoud F et al (2016) Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the Global SYMPLICITY Registry. Eur Heart J 38(2):93\u2013100","journal-title":"Eur Heart J"},{"issue":"8","key":"2421_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jash.2014.06.001","volume":"8","author":"M Esler","year":"2014","unstructured":"Esler M (2014) Illusions of truths in the Symplicity HTN-3 trial: generic design strengths but neuroscience failings. J Am Soc Hypertens 8(8):593\u2013598","journal-title":"J Am Soc Hypertens"},{"issue":"2","key":"2421_CR23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00330-003-2022-5","volume":"14","author":"D Stoeckel","year":"2004","unstructured":"Stoeckel D, Pelton A, Duerig T (2004) Self-expanding nitinol stents: material and design considerations. Eur Radiol 14(2):292\u2013301","journal-title":"Eur Radiol"},{"key":"2421_CR24","unstructured":"\u201cGlobal Clinical Study of Renal Denervation With the Symplicity SpyralTM Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension in the Absence of Antihypertensive Medications (SPYRAL PIVOTAL - SPYRAL HTN-OFF MED) (NCT02439749)\u201d"},{"key":"2421_CR25","unstructured":"\u201cGlobal Clinical Study of Renal Denervation With the Symplicity SpyralTM Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED) (NCT02439775)\u201d"},{"issue":"4","key":"2421_CR26","first-page":"321","volume":"14","author":"J K\u0105dziela","year":"2018","unstructured":"K\u0105dziela J, Warcho\u0142-Celi\u0144ska E, Prejbisz A et al (2018) Renal denervation - can we press the \u2018ON\u2019 button again? Postep w Kardiol interwencyjnej = Adv Interv Cardiol 14(4):321\u2013327","journal-title":"Postep w Kardiol interwencyjnej = Adv Interv Cardiol"},{"key":"2421_CR27","unstructured":"T. Neale, \u201cPrematurely halted pilot study snaps recent winning streak for renal denervation,\u201d Cardiovascular Research Foundation, 2018. [Online]. Available: https:\/\/www.tctmd.com\/news\/prematurely-halted-pilot-study-snaps-recent-winning-streak-renal-denervation. Accessed 27 April 2020"},{"key":"2421_CR28","unstructured":"\u201cTreatment of Resistant Hypertension Using a Radiofrequency Percutaneous Transluminal Angioplasty Catheter (REDUCE-HTN) - POST MARKET APPROVAL CLINICAL SURVEILLANCE STUDY (NCT01541865)\u201d"},{"key":"2421_CR29","doi-asserted-by":"crossref","unstructured":"Sievert H et al \u201cRenal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study,\u201d EuroIntervention, vol. 10, no. 10, pp. 1213\u20131220, Feb. 20 AD","DOI":"10.4244\/EIJY14M12_01"},{"key":"2421_CR30","unstructured":"\u201cA Boston Scientific Clinical Trial of Renal Denervation Using the Vessix ReduceTM Catheter and VessixTM Generator for the Treatment of HyperTensioN: REINFORCE ( NCT02392351)\u201d"},{"issue":"4","key":"2421_CR31","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1523\/JNEUROSCI.03-04-00714.1983","volume":"3","author":"PT Manning","year":"1983","unstructured":"Manning PT, Powers CW, Schmidt RE et al (1983) Guanethidine-induced destruction of peripheral sympathetic neurons occurs by an immune-mediated mechanism. J Neurosci 3(4):714\u2013724","journal-title":"J Neurosci"},{"key":"2421_CR32","unstructured":"Rocha-Singh KJ \u201cRenal artery denervation: a brave new frontier\u201d. Endovasc Today. no. February 2012"},{"issue":"6","key":"2421_CR33","doi-asserted-by":"publisher","first-page":"589 LP","DOI":"10.1016\/j.jcin.2015.11.041","volume":"9","author":"TA Fischell","year":"2016","unstructured":"Fischell TA et al (2016) Transcatheter alcohol-mediated perivascular renal denervation with the Peregrine System. JACC Cardiovasc Interv 9(6):589 LP\u2013589598","journal-title":"JACC Cardiovasc Interv"},{"key":"2421_CR34","unstructured":"\u201cA Phase 2, Multicenter, Blinded, Sham Procedure-Controlled Trial of Renal Denervation by the Peregrine System Kit, in Subjects With Hypertension, in the Absence of Antihypertensive Medications (NCT03503773)\u201d"},{"key":"2421_CR35","unstructured":"\u201cTARGET BP I Trial: A Phase 3, Multicenter, Blinded, Sham-Procedure Controlled Trial of Renal Denervation by the Peregrine SystemTM Kit, in Subjects With Hypertension (NCT02910414)\u201d"},{"key":"2421_CR36","unstructured":"\u201cCRT 2019: Peregrine catheter demonstrated 100% procedural success in post-market clinical trial,\u201d Cardiovascular News, 2019. [Online]. Available:https:\/\/cardiovascularnews.com\/peregrine-catheter\/. Accessed 2 May 2020"},{"issue":"6","key":"2421_CR37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1111\/joic.12343","volume":"29","author":"G Imnadze","year":"2016","unstructured":"Imnadze G, Balzer S, Meyer B et al (2016) Anatomic patterns of renal arterial sympathetic innervation: new aspects for renal denervation. J Interv Cardiol 29(6):594\u2013600","journal-title":"J Interv Cardiol"},{"key":"2421_CR38","unstructured":"\u201cClinical Evaluation of the Therapeutic Intra-Vascular Ultrasound (TIVUSTM) System for Renal Denervation in Patients With Resistant Hypertension (NCT01835535)\u201d"},{"issue":"8","key":"2421_CR39","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.jvir.2018.03.022","volume":"29","author":"G Chernin","year":"2018","unstructured":"Chernin G, Szwarcfiter I, Scheinert D et al (2018) First-in-man experience with a novel catheter-based renal denervation system of ultrasonic ablation in patients with resistant hypertension. J Vasc Interv Radiol 29(8):1158\u20131166","journal-title":"J Vasc Interv Radiol"},{"key":"2421_CR40","unstructured":"\u201cAblation-induced Renal Sympathetic Denervation Trial (NCT01438229)\u201d"},{"key":"2421_CR41","unstructured":"\u201cInternational Non-randomized, Single-arm, Long-term Follow-up Study of Patients With Uncontrolled Hypertension (NCT01705080)\u201d"},{"key":"2421_CR42","unstructured":"\u201cInternational First-in-Human Study of the EnligHTN Generation 2 System in Patients With Drug-resistant Uncontrolled Hypertension (NCT01836146)\u201d"},{"issue":"28","key":"2421_CR43","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1093\/eurheartj\/eht197","volume":"34","author":"SG Worthley","year":"2013","unstructured":"Worthley SG, Tsioufis CP, Worthley MI et al (2013) Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 34(28):2132\u20132140","journal-title":"Eur Heart J"},{"key":"2421_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.atherosclerosis.2017.04.022","volume":"262","author":"SG Worthley","year":"2017","unstructured":"Worthley SG, Wilkins GT, Webster MW et al (2017) Safety and performance of the second generation EnligHTNTM renal denervation system in patients with drug-resistant, uncontrolled hypertension. Atherosclerosis 262:94\u2013100","journal-title":"Atherosclerosis"},{"key":"2421_CR45","unstructured":"\u201cMulti-center, Randomized, Single-blind, Sham Controlled Clinical Investigation of Renal Denervation for Uncontrolled Hypertension (NCT01903187)\u201d"},{"key":"2421_CR46","unstructured":"\u201cRenal Sympathetic Denervation by Iberis System in Patients With Uncontrolled Hypertension - IBERIS - HTN Registry (NCT02295683)\u201d"},{"issue":"3","key":"2421_CR47","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000490620","volume":"6","author":"K Kario","year":"2018","unstructured":"Kario K, Rumoroso JR, Okawara Y et al (2018) Renal sympathetic denervation in patients with resistant hypertension: a feasibility study. Pulse 6(3):137\u2013143","journal-title":"Pulse"},{"issue":"Suppl 26","key":"2421_CR48","doi-asserted-by":"publisher","first-page":"S3060","DOI":"10.21037\/jtd.2018.08.134","volume":"10","author":"S Torii","year":"2018","unstructured":"Torii S, Mori H, Jinnouchi H et al (2018) Renal denervation with ultrasound therapy (paradise device) is an effective therapy for systemic hypertension. J Thorac Dis 10(Suppl 26):S3060\u2013S3063","journal-title":"J Thorac Dis"},{"key":"2421_CR49","unstructured":"\u201cThe RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension (NCT03614260)\u201d"},{"key":"2421_CR50","unstructured":"\u201c\u2018A Clinical Study of the Ultrasound Renal Denervation System in Patients with Resistant Hypertension\u2019 (NCT02918305)\u201d"},{"key":"2421_CR51","unstructured":"\u201c\u2018Wave IV Study: Phase II Randomized Sham Controlled Study of Renal Denervation for Subjects with Uncontrolled Hypertension\u2019 (NCT02029885)\u201d"},{"key":"2421_CR52","unstructured":"Dawood O, Baumgart P, Brien BO et al (2017) Phase II randomized sham-controlled study of renal denervation for individuals with uncontrolled hypertension- WAVE IV. J Hypertens:1\u201310"},{"key":"2421_CR53","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/eurheartj\/ehx215","volume":"38","author":"F Mahfoud","year":"2017","unstructured":"Mahfoud F, Schmieder RE, Azizi M et al (2017) Proceedings from the 2nd European Clinical Consensus Conference for device-based therapies for hypertension : state of the art and considerations for the future. Eur Heart J 38:3272\u20133281","journal-title":"Eur Heart J"},{"issue":"6","key":"2421_CR54","doi-asserted-by":"publisher","first-page":"790","DOI":"10.4103\/0366-6999.152621","volume":"128","author":"M Ji","year":"2015","unstructured":"Ji M, Shen L, Wu YZ et al (2015) Short-term safety and efficiency of cryoablation for renal sympathetic denervation in a swine model. Chin Med J 128(6):790\u2013794","journal-title":"Chin Med J"},{"key":"2421_CR55","unstructured":"Ge J et al (2019) \u201cValidation of a novel catheter-based renal denervation system of cryoablation ( Cryo-RDN ) in patients with resistant hypertension : a first-in-man study\u201d in EuroPCR"},{"key":"2421_CR56","unstructured":"\u201c\u2018Safety and efficacy of a prospective, multicentre, randomized, parallel-controlled renal denervation system for the treatment of essential hypertension and renal hypertension\u2019 (ChiCTR1800017815)\u201d"},{"issue":"3","key":"2421_CR57","first-page":"2","volume":"2019","author":"Y Li","year":"2019","unstructured":"Li Y, Nawabi AQ, Feng Y et al (2019) Safety and efficacy of a new renal denervation catheter in hypertensive patients in the absent of antihypertensive medications: a pilot study. Hindawi Int J Hypertens 2019(3):2\u20136","journal-title":"Hindawi Int J Hypertens"},{"key":"2421_CR58","unstructured":"\u201c\u2018A Prospective, Multicentre, Randomized, Controlled Study of Assessing the Safety and Efficacy of Sterile Irrigated Deflectable Ablation Catheter Used in Renal Artery in Primary Hypertension\u2019 (NCT03511313)\u201d"},{"key":"2421_CR59","unstructured":"(United States of America Patent No. 9375154, 2016)"},{"key":"2421_CR60","unstructured":"\u201c\u2018A Prospective, Multicentre, Single-Blind, Randomized and Controlled Trial of Renal Sympathetic Denervation Using SyMapCath ITM Catheter and SYMPIONEER S1TM Stimulator\/Generator for the Treatment of Hypertension (SMART Trial)\u2019 (NCT02761811)\u201d"},{"key":"2421_CR61","unstructured":"Tsioufis C (2018) \u201cConfidenHT system - renal nerve mapping using electrical stimulation for a renal sympathetic denervation procedure,\u201d in EuroPCR"},{"key":"2421_CR62","doi-asserted-by":"crossref","unstructured":"Tsioufis K et al (2018) Safety and performance of diagnostic electrical mapping of renal nerves in hypertensive patients. EuroIntervention 14(12)","DOI":"10.4244\/EIJ-D-18-00536"},{"key":"2421_CR63","unstructured":"ConfidenHT System Safety and Performance of Diagnostic Electrical Mapping of Renal Nerves in Hypertensive Patients and\/or Potential Candidates for a Renal Sympathetic Denervation (RDN) Procedure\u2019(NCT02777216)"}],"container-title":["Irish Journal of Medical Science (1971 -)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-020-02421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11845-020-02421-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11845-020-02421-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T08:24:46Z","timestamp":1627028686000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11845-020-02421-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,28]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["2421"],"URL":"https:\/\/doi.org\/10.1007\/s11845-020-02421-1","relation":{},"ISSN":["0021-1265","1863-4362"],"issn-type":[{"value":"0021-1265","type":"print"},{"value":"1863-4362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,28]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}